10 Nov Top Stories From The Edge – Week of November 5th
A Weekly Roundup of Stories We Found Interesting – From The Profound To The Profane
The Departure of Attorney General Jeff Sessions Could Be Good for Weed Advocates
The fate of federal marijuana regulation got a jolt Wednesday with U.S. Attorney General Jeff Sessions, resigning from his post. Sessions, a hard-lined advocate for enforcing federal laws that prohibit marijuana cultivation, sale and use, has been replaced, at least for now, by his chief of staff, Matthew Whitaker. Weed investors rejoice.
The U.S. Marijuana Movement Proves Unwavering As Voters Go Green In The 2018 Midterms
During the 2018 midterm elections, four states had some form of marijuana legalization on the ballot. Michigan and North Dakota put recreational up to a vote, while residents of Missouri and Utah decided whether to legalize medical marijuana. The initiatives were successful in three of the four states—only North Dakotans struck down the initiative.
Disgraced at Olympics Over Marijuana, Canadian Snowboarder Hopes to Ride to Cannabis Success
Twenty years ago, when he was 26, Mr. Rebagliati came to global fame — and infamy — after winning a gold medal in the giant slalom at the 1998 Nagano Winter Olympics in Japan. But his Olympic dreams subsequently imploded after he tested positive for cannabis and was stripped of the medal. He is hoping that Canada’s action to legalize marijuana last month will bring him closure, business opportunity and, perhaps most importantly, vindication.
Mexico Moves Toward Major Rollback of Marijuana Prohibition
Mexico’s next interior minister plans to submit a bill to create a medical marijuana industry and allow recreational use. If the bill passes, Mexico would join Canada, Uruguay and a host of U.S. states that permit recreational use of the drug and allow its commercialization. It would be one of the most populous countries to roll back prohibition.
The Most Impactful Cannabis Studies of All Time
The following compendium of landmark cannabis studies is exclusively focused on top-level research that either fundamentally advanced our understanding of the plant’s therapeutic properties, or thoroughly debunked some pernicious piece of official misinformation.